Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity-Reference-Cited by-同舟云学术

Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity

Published:2020-08 Issue: Volume:13 Page:107-120
ISSN:2211-3207
Container-title:International Journal for Parasitology: Drugs and Drug Resistance
language:en
Short-container-title:International Journal for Parasitology: Drugs and Drug Resistance

Author:

Franco Caio H.,Warhurst David C.,Bhattacharyya Tapan,Au Ho Y.A.^ORCID,Le Hai,Giardini Miriam A.^ORCID,Pascoalino Bruno S.,Torrecilhas Ana Claudia,Romera Lavinia M.D.,Madeira Rafael Pedro^ORCID,Schenkman Sergio^ORCID,Freitas-Junior Lucio H.,Chatelain Eric,Miles Michael A.,Moraes Carolina B.

Funder

DNDi

Institut Pasteur Korea

Federal Ministry of Education and Research (KfW-BMBF)/Germany

Médecins Sans Frontières (Doctors without Borders)/International

Department for International Development (DFID), UK

Directorate-General for International Cooperation (DGIS), The Netherlands

Swiss Agency for Development and Cooperation

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Parasitology

Reference67 articles.

1. Chagas disease in Europe: a review for the internist in the globalized world;Antinori;Eur. J. Intern. Med.,2017

2. New mechanisms of drug resistance in parasitic protozoa;Borst;Annu. Rev. Microbiol.,1995

3. Cloning and analysis of Trypanosoma cruzi lanosterol 14α-demethylase;Buckner;Mol. Biochem. Parasitol.,2003

4. Induction of resistance to azole drugs in Trypanosoma cruzi;Buckner;Antimicrob. Agents Chemother.,1998

5. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media;Camargo;Rev. Inst. Med. Trop. Sao Paulo,1964

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Novel Drugs for the Treatment of Chagas Disease;Current Topics in Zoonoses [Working Title];2023-09-10

2. Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection;Journal of Medicinal Chemistry;2023-01-06

3. Molecular Characterization of Four Mexican Isolates of Trypanosoma cruzi and Their Profile Susceptibility to Nifurtimox;Acta Parasitologica;2022-08-27

4. The Transcription Factor FgAtrR Regulates Asexual and Sexual Development, Virulence, and DON Production and Contributes to Intrinsic Resistance to Azole Fungicides in Fusarium graminearum;Biology;2022-02-18

5. The translational challenge in Chagas disease drug development;Memórias do Instituto Oswaldo Cruz;2022